(Total Views: 190)
Posted On: 07/30/2020 12:10:57 PM
Post# of 89062
$LXRX News Article - Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program https://marketwirenews.com/news-releases/lexi...81899.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
